When are statins cost-effective in cardiovascular prevention? A systematic review of sponsorship bias and conclusions in economic evaluations of statins.

When are statins cost-effective in cardiovascular prevention? A systematic review of sponsorship bias and conclusions in economic evaluations of statins.

We examined sponsorship of published cost-effectiveness analyses of statin use for cardiovascular (CV) prevention, and determined whether the funding source is associated with study conclusions.We searched PubMed/MEDLINE (up to June 2011) to identify cost-effectiveness analyses of statin use for CV...

Full description

Bibliographic Details
Main Authors: Ferrán Catalá-López, Gabriel Sanfélix-Gimeno, Manuel Ridao, Salvador Peiró
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3704635?pdf=render

Internet

http://europepmc.org/articles/PMC3704635?pdf=render

Similar Items